Sukmo Kang
Daejeon, Republic of Korea
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 22 publications
KB-0118, A novel BET bromodomain inhibitor, suppresses Th17-mediated inflammation in inflammatory bowel disease.
Journal: Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie
Published: December 24, 2024
Neoantigen-Displaying Protein Nanoparticles as a Therapeutic Cancer Vaccine Against Melanoma.
Journal: Advanced healthcare materials
Published: November 03, 2024
Methyl p‑hydroxycinnamate exerts anti‑inflammatory effects in mouse models of lipopolysaccharide‑induced ARDS.
Journal: Molecular medicine reports
Published: August 27, 2021
Sequential and Timely Combination of a Cancer Nanovaccine with Immune Checkpoint Blockade Effectively Inhibits Tumor Growth and Relapse.
Journal: Angewandte Chemie (International ed. in English)
Published: April 28, 2020
PEGylated Bilirubin-coated Iron Oxide Nanoparticles as a Biosensor for Magnetic Relaxation Switching-based ROS Detection in Whole Blood.
Journal: Theranostics
Published: August 26, 2019
Antibody-Assisted Delivery of a Peptide-Drug Conjugate for Targeted Cancer Therapy.
Journal: Molecular pharmaceutics
Published: December 07, 2018
Polymer Thin Film-Induced Tumor Spheroids Acquire Cancer Stem Cell-like Properties.
Journal: Cancer research
Published: March 28, 2018
Magnetic Resonance Imaging-Guided Drug Delivery to Breast Cancer Stem-Like Cells.
Journal: Advanced healthcare materials
Published: March 14, 2018
Targeted Cancer Therapy Using Fusion Protein of TNFα and Tumor-Associated Fibronectin-Specific Aptide.
Journal: Molecular pharmaceutics
Published: October 04, 2017
Bilirubin nanoparticle preconditioning protects against hepatic ischemia-reperfusion injury.
Journal: Biomaterials
Published: April 07, 2017
Last Updated: 09/26/2026